Tracked deals
7
7 tracked deals across 2021-2025.
Operating Company
Healthcare
Revelation Pharma
Kennesaw, Georgia, United States
Revelation Pharma is a national network of 503A and 503B compounding pharmacies providing innovative and quality pharmaceutical products and services through industry-best patient care and solutions.
- Focus Areas
- Compounding Pharmacy (503A), Outsourced Compounding Pharmacy (503B), Specialty Pharmacy
- Website
- revelationpharma.com
Recent pace
0
0 tracked deals announced in the last 12 months.
Deal mix
Addon
5 addon · 2 buyout
Revelation Pharma Acquisition Volume by Year
Last 5 years
Supporting Data
Recent Transactions
-
October 9, 2025
- Buyer
- Revelation Pharma
- Target
- Acacia Apothecary & Wellness
- Seller
- Justin Brock, Heather Brock
- Industry
- Healthcare Services
- Location
- Arizona, United States
- Type
- Addon
Revelation Pharma, a national network of 503A and 503B compounding pharmacies, has acquired Acacia Apothecary & Wellness, a Tucson-based compounding pharmacy. The deal expands Revelation's footprint and expertise in hormone therapy, women's health, and personalized medicine; Acacia founder Justin Brock, PharmD, will join Revelation as an Operational Consultant.
-
January 22, 2025
- Buyer
- Revelation Pharma
- Target
- Cascade Specialty Pharmacy
- Seller
- Brandon Knott
- Industry
- Healthcare Services
- Location
- Washington, United States
- Type
- Buyout
Revelation Pharma, a national network of 503A and 503B compounding pharmacies, has acquired Cascade Specialty Pharmacy of Poulsbo, Washington. The acquisition expands Revelation Pharma's ENT and animal-health compounding capabilities and brings Cascade's existing customers and product lines into Revelation's national fulfillment network; Cascade's former owner Brandon Knott will remain involved as an ENT Allergy Product Specialist.
-
- Buyer
- Revelation Pharma
- Target
- Taylors Pharmacy, Key Compounding Pharmacy
- Seller
- Allen Deaver, HeeJoo Park
- Industry
- Healthcare Services
- Location
- United States
- Type
- Addon
Revelation Pharma, a national network of 503A and 503B compounding pharmacies, has acquired Taylors Pharmacy (Florida) and Key Compounding Pharmacy (Federal Way, Washington). The acquisitions expand Revelation's coast-to-coast footprint and bring both pharmacies into its compounding network as Revelation assumes full operations; the sellers are the founders/owners Allen Deaver and HeeJoo Park.
-
July 13, 2023
- Buyer
- Revelation Pharma, Osceola Capital Management
- Target
- Eagle Pharmacy, Lee Silsby Compounding Pharmacy
- Industry
- Healthcare Services
- Location
- United States
- Type
- Addon
Osceola Capital’s platform company Revelation Pharma acquired Eagle Pharmacy (Hoover, Alabama) and Lee Silsby Compounding Pharmacy (Beachwood, Ohio), marking the seventeenth and eighteenth add-ons to the Revelation platform. The acquisitions expand Revelation’s 503A/503B compounding capabilities and geographic reach, adding scale, diversification, and capacity to serve patients, prescribers, and healthcare facilities nationwide.
-
October 12, 2022
- Buyer
- Revelation Pharma Corporation, Osceola Capital Management
- Target
- Harrow Health (non-ophthalmic compounding business)
- Seller
- Harrow Health
- Industry
- Healthcare Services
- Location
- Tennessee, United States
- Type
- Addon
Osceola Capital-backed Revelation Pharma has acquired the non-ophthalmic compounding business of NASDAQ-listed Harrow Health as the twelfth add-on to the Revelation platform. The deal lets Revelation expand its national footprint of 503A and 503B compounding pharmacies while Harrow focuses solely on ophthalmic medications.
-
- Buyer
- Revelation Pharma, Osceola Capital
- Target
- Innovation Compounding, Pencol Compounding Pharmacy, Pharmacy Specialists Compounding, Wise Pharmacy, Convex Pharmacy
- Industry
- Healthcare Services
- Location
- United States
- Type
- Addon
Revelation Pharma, a PE-backed specialty pharmacy platform sponsored by Osceola Capital, completed add-on acquisitions of five compounding pharmacies: Innovation Compounding, Pencol Compounding Pharmacy, Pharmacy Specialists Compounding, Wise Pharmacy, and Convex Pharmacy. The deals expand Revelation's geographic footprint and clinical capabilities across key U.S. regions and will see some locations merged into existing Revelation businesses (e.g., Wise into Pencol; Convex into Everwell).
-
- Buyer
- Revelation Pharma Corp, Osceola Capital
- Target
- Everwell Specialty Pharmacy
- Industry
- Healthcare Services
- Location
- Florida, United States
- Type
- Buyout
Osceola Capital formed Revelation Pharma Corp as a pharmacy compounding platform in partnership with industry veteran Jacob Beckel and concurrently completed the acquisition of Pensacola-based Everwell Specialty Pharmacy. Revelation will pursue consolidation of 503A compounding pharmacies nationally, with Everwell serving as the initial platform asset focused on anti-infectives, specialty compounding and other therapeutic classes.
Related Acquisition Pages
Healthcare Services Buyers & Acquisitions
7 tracked deals by Revelation Pharma.
Acquisitions in Arizona
1 tracked deal by Revelation Pharma.
Acquisitions in Florida
1 tracked deal by Revelation Pharma.
Acquisitions in Tennessee
1 tracked deal by Revelation Pharma.
Acquisitions in Washington
1 tracked deal by Revelation Pharma.
Selling a company? Get in front of buyers like Revelation Pharma
Turn tracked acquisition activity into an outreach-ready buyer list.